Orange Book product · Brand (NDA)
NOCTIVA
DESMOPRESSIN ACETATE
At a glance
Mar 03, 2017
Approved
Brand (NDA)
Application
Not listed
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 03, 2017
9 yr 5 mo ago
Today
Patent 11419914 expires
Listed method-of-use patent (U-3431) expiration.
Jun 15, 2030
in 4 yr 1 mo
Patent 12090190 expires
Listed drug product patent expiration.
Jun 15, 2030
in 4 yr 1 mo
Patent 9539302 expires
Listed drug product patent expiration.
Jun 15, 2030
in 4 yr 1 mo
Pharmaceutical detail
Active ingredient
DESMOPRESSIN ACETATE
Strength
0.00083MG/SPRAY
Dosage form
SPRAY, METERED
Route
NASAL
TE code
Not listed
Application
NDA 201656
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2026DESMODABrand (NDA)
NDA 219873 · ETON
- 2018NOCDURNABrand (NDA)
NDA 022517 · FERRING PHARMS INC
- 2008DESMOPRESSIN ACETATEBrand (NDA)
NDA 021795 · FERRING
- 2002MINIRINBrand (NDA)
NDA 021333 · FERRING
- 1995DDAVPBrand (NDA)
NDA 019955 · FERRING PHARMS INC
- 1994STIMATEBrand (NDA)
NDA 020355 · FERRING PHARMS INC
- 1990CONCENTRAIDBrand (NDA)
NDA 019776 · FERRING
- 1984DDAVPBrand (NDA)
NDA 018938 · NORDIC PHARMA
- —DDAVPBrand (NDA)
NDA 017922 · FERRING PHARMS INC
- 2026DESMOPRESSIN ACETATEGeneric (ANDA)
ANDA 219981 · CAPLIN
- 2024DESMOPRESSIN ACETATEGeneric (ANDA)
ANDA 213095 · AUROBINDO PHARMA
- 2023DESMOPRESSIN ACETATEGeneric (ANDA)
ANDA 216904 · GLAND
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11419914 | Jun 15, 2030 | in 4 yr 1 mo | U-3431 |
| 12090190 | Jun 15, 2030 | in 4 yr 1 mo | ProductU-4003 |
| 9539302 | Jun 15, 2030 | in 4 yr 1 mo | Product |

